# COVID-19 Infection in Patients Receiving Anti-CD20 Therapy

> **NCT04884477** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 342 (actual)

## Conditions studied

- COVID-19
- Immunosuppressed Host
- Convalescent Plasma
- Anti-CD20 Therapy

## Interventions

- **BIOLOGICAL:** Convalescent Plasma

## Key facts

- **NCT ID:** NCT04884477
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2023-01-15
- **Final completion:** 2023-01-15
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04884477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04884477, "COVID-19 Infection in Patients Receiving Anti-CD20 Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04884477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*